Successful treatment of extramedullary plasmacytoma of the cavernous sinus using a combination of intermediate dose of thalidomide and dexamethasone

Acta Haematol. 2007;117(1):20-3. doi: 10.1159/000096862. Epub 2006 Nov 10.

Authors

Eirini Katodritou¹, Matthaios Speletas, Anastasia Pouli, John Tsitouridis, Konstantinos Zervas, Evangelos Terpos

Affiliation

¹ Department of Haematology, Papageorgiou General Hospital, Thessaloniki, Greece.

PMID: 17106187
DOI: 10.1159/000096862

No abstract available

Publication types

Case Reports

MeSH terms

Angiogenesis Inhibitors / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cavernous Sinus / pathology*
Dexamethasone / administration & dosage
Diplopia / etiology
Doxorubicin / administration & dosage
Female
Humans
Magnetic Resonance Imaging
Middle Aged
Neoplasms, Vascular Tissue / complications
Neoplasms, Vascular Tissue / drug therapy*
Neoplasms, Vascular Tissue / pathology
Plasmacytoma / complications
Plasmacytoma / drug therapy*
Plasmacytoma / pathology
Remission Induction
Thalidomide / administration & dosage
Vincristine / administration & dosage

Substances

Angiogenesis Inhibitors
Thalidomide
Vincristine
Dexamethasone
Doxorubicin

Supplementary concepts

VAD I protocol